⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

September 4, 2024Frontiers in MedicineOpen Access

Influence of rheumatoid factor levels and TNF inhibitor structure on secondary nonresponse in rheumatoid arthritis patients

Chamaida Plasencia‐Rodríguez Ana Martínez‐Feito Marta Novella-Navarro Rebeca Pérez de Diego Gema Bonilla Johanna Elin Gehin Alejandro Villalba-Yllán Laura Nuño Dora Pascual‐Salcedo Pilar Nozal Mariana Díaz Almirón Alejandro Balsa

View Full Paper

Ask AI

Bookmark

Share

Abstract

The EXXELERATE study revealed poorer clinical outcomes in patients treated with adalimumab (ADL) and baseline rheumatoid factor (RF) above 203 IU/mL. However, responses were similar in patients treated with certolizumab pegol (CZP) regardless of RF levels.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Plasencia‐Rodríguez et al. (2024) studied this question.

synapsesocial.com/papers/68e59566b6db6435875307df https://doi.org/10.3389/fmed.2024.1461396

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Impact of high rheumatoid factor levels on treatment outcomes with certolizumab pegol and adalimumab in patients with rheumatoid arthritis2024 · 20 citations
2Do high rheumatoid factor levels impact response to certolizumab pegol in patients with inadequately controlled rheumatoid arthritis? A post hoc analysis of the phase IIIb REALISTIC trialLate-Phase Clinical Trial · 2026 · 2 citations
3Infliximab exposure, clinical response, and inflammatory biomarkers in patients with rheumatoid arthritis: a descriptive study2024
4Optimising Therapeutic Intervals for Anti-TNF Biologics in Rheumatoid Arthritis: A Retrospective Real-World StudyCohort Study · 2026
5Association of rheumatoid factor, anti-citrullinated protein antibodies and shared epitope with clinical response to initial treatment in patients with early rheumatoid arthritis: data from a randomised controlled trial2024 · 14 citations